Edition:
United States

Silence Therapeutics PLC (SLN.L)

SLN.L on London Stock Exchange

118.00GBp
23 Sep 2016
Change (% chg)

-1.00p (-0.84%)
Prev Close
119.00p
Open
118.00p
Day's High
118.00p
Day's Low
118.00p
Volume
12,341
Avg. Vol
43,284
52-wk High
260.00p
52-wk Low
96.62p

SLN.L

Chart for SLN.L

About

Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a... (more)

Overall

Beta: 1.62
Market Cap(Mil.): £82.37
Shares Outstanding(Mil.): 69.80
Dividend: --
Yield (%): --

Financials

  SLN.L Industry Sector
P/E (TTM): -- 42.52 36.60
EPS (TTM): -0.11 -- --
ROI: -15.07 -0.26 13.91
ROE: -15.07 -3.05 14.82

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : GlobalData
$300.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.